UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 260

Sortiert nach

An investigation on the mortality during a smog situation in western Ruhrgebiet on the 17. January 1979 (author's transl)

Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale B, Hygiene, 1980-09, Vol.171 (4-5), p.445

Steiger, H

1980

Link zum Volltext

Verfügbarkeit prüfen

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study

Annals of the rheumatic diseases, 2013-10, Vol.72 (10), p.1605-1612

2013

Link zum Volltext

Verfügbarkeit prüfen

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

Clinical infectious diseases, 2016-09, Vol.63 (5), p.e61-e111

2016

Link zum Volltext

Verfügbarkeit prüfen

Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study

Rheumatology (Oxford, England), 2019-05, Vol.58 (5), p.859-868

2019

Link zum Volltext

Verfügbarkeit prüfen

Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Study

Arthritis & rheumatology (Hoboken, N.J.), 2021-01, Vol.73 (1), p.110-120

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Annals of the rheumatic diseases, 2014-01, Vol.73 (1), p.39-47

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)

Annals of the rheumatic diseases, 2020-02, Vol.79 (2), p.176

2020

Link zum Volltext

Verfügbarkeit prüfen

Carinal sleeve resection: last exit for bronchial insufficiency—a 17-year, single-centre experience

Interactive cardiovascular and thoracic surgery, 2021-05, Vol.32 (6), p.921-927

2021

Link zum Volltext

Verfügbarkeit prüfen

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

Thorax, 2009-12, Vol.64 (12), p.1062-1069

2009

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis

Rheumatic & musculoskeletal diseases open, 2022-06, Vol.8 (2), p.e002383

2022

Link zum Volltext

Verfügbarkeit prüfen

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial

Annals of the rheumatic diseases, 2018-05, Vol.77 (5), p.699

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis

Rheumatic & musculoskeletal diseases open, 2024-01, Vol.10 (1), p.e003733

2024

Link zum Volltext

Verfügbarkeit prüfen

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study

Annals of the rheumatic diseases, 2015-04, Vol.74 (4), p.757-761

2015

Link zum Volltext

Verfügbarkeit prüfen

New developments in ankylosing spondylitis—status in 2021

Rheumatology (Oxford, England), 2021-12, Vol.60 (Supplement_6), p.vi29-vi37

2021

Link zum Volltext

Verfügbarkeit prüfen

Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19

Respiration, 2020-07, Vol.99 (6), p.521-542

2020

Link zum Volltext

Verfügbarkeit prüfen

TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort

Annals of the rheumatic diseases, 2018-01, Vol.77 (1), p.63

2018

Link zum Volltext

Verfügbarkeit prüfen

A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany

The European respiratory journal, 2022-02, Vol.59 (2), p.2102432

2022

Link zum Volltext

Verfügbarkeit prüfen

Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients

Rheumatology (Oxford, England), 2018-08, Vol.57 (8), p.1390-1399

2018

Link zum Volltext

Verfügbarkeit prüfen

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

Annals of the rheumatic diseases, 2003-09, Vol.62 (9), p.817-824

2003

Link zum Volltext

Verfügbarkeit prüfen

Ultrafine and Fine Particle Number and Surface Area Concentrations and Daily Cause-Specific Mortality in the Ruhr Area, Germany, 2009-2014

Environmental health perspectives, 2018-02, Vol.126 (2), p.027008-027008

2018

Link zum Volltext

Verfügbarkeit prüfen

Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

Annals of the rheumatic diseases, 2007-07, Vol.66 (7), p.910-915

2007

Link zum Volltext

Verfügbarkeit prüfen

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1051-1057

2015

Link zum Volltext

Verfügbarkeit prüfen

Axial spondyloarthritis including ankylosing spondylitis

Rheumatology (Oxford, England), 2018-11, Vol.57 (suppl_6), p.vi1-vi3

Braun, Jürgen

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 260

Suche als RSS-Feed

Aktive Filter

KollektionDe Gruyter journals

ThemaEarth And Environmental Science

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(222)
Mit Volltextzugriff
(216)

Publikationsform

Artikel
(260)

Sprache

Englisch
(224)
Deutsch
(40)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(217)
Life Sciences & Biomedicine
(213)
Rheumatology
(129)
Male
(126)
Female
(125)
Adult
(99)
Middle Aged
(88)
Biological And Medical Sciences
(58)
Medical Sciences
(55)
Treatment Outcome
(54)
Spondylitis, Ankylosing - Drug Therapy
(53)
Aged
(52)
Ankylosing Spondylitis
(48)
Patients
(47)
Antirheumatic Agents - Therapeutic Use
(45)
Severity Of Illness Index
(38)
Arthritis
(37)
Adolescent
(33)
Diseases Of The Osteoarticular System
(33)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

An investigation on the mortality during a smog situation in western Ruhrgebiet on the 17. January 1979 (author's transl)

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study

Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study

Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo‐Controlled Phase III Study

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)

Carinal sleeve resection: last exit for bronchial insufficiency—a 17-year, single-centre experience

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

High prevalence of chondrocalcinosis and frequent comorbidity with calcium pyrophosphate deposition disease in patients with seronegative rheumatoid arthritis

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial

Clinically relevant differences in spinal mobility related to daytime performance in patients with axial spondyloarthritis

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study

New developments in ankylosing spondylitis—status in 2021

Position Paper for the State-of-the-Art Application of Respiratory Support in Patients with COVID-19

TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort

A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany

Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

Ultrafine and Fine Particle Number and Surface Area Concentrations and Daily Cause-Specific Mortality in the Ruhr Area, Germany, 2009-2014

Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)

Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial

Axial spondyloarthritis including ankylosing spondylitis

Aktive Filter

Suchergebnisse filtern